Effect of Blumgart anastomosis in reducing the incidence rate of pancreatic fistula after pancreatoduodenectomy

Table 1 Demographic and clinical characteristics of 291 patients

	Blumgart anastomosis	Embedded anastomosis	P-value
No. of patients	201	90
Age, mean ± SE, yr	53.28 ± 1.35	54.54 ± 1.81	0.584
Sex (male/female)	109/92	41/49	0.172
Past medical history, n (%)
Diabetes mellitus	40 (19.9)	20 (22.2)	0.652
Cholecystolithiasis	39 (19.4)	20 (22.2)	0.582
Cardiovascular disease	50 (24.9)	28 (31.1)	0.269
Personal medical history, n (%)
Smoking	97 (48.3)	50 (55.6)	0.251
Drinking	53 (26.4)	25 (27.8)	0.803
Preoperative lab test, mean ± SE
Serum albumin, g/L	41.82 ± 1.54	40.50 ± 1.41	0.552
Total bilirubin, μmol/L	69.53 ± 13.8	54.87 ± 15.1	0.510
Direct bilirubin, μmol/L	49.66 ± 11.0	41.53 ± 13.0	0.653
Cancer antigen 19-9, U/L	239.6 ± 41.9	248.5 ± 53.9	0.896
Diameter of the mass, mean ± SE, cm	3.46 ± 0.23	3.06 ± 0.29	0.314
Type of neoplasms, n (%)
Pancreatic ductal adenocarcinoma	137 (68.2)	65 (72.2)	0.489
Intraductal papillary mucinous neoplasm	6 (3.0)	2 (2.2)	0.714
Cystic lesion	10 (4.9)	4 (4.4)	0.846
Neuroendocrine tumor	6 (3.0)	3 (3.3)	0.875
Solid-pseudopapillary tumor	13 (6.5)	6 (6.7)	0.950
Pancreatitis	10 (4.9)	5 (5.6)	0.837
Others	19 (9.5)	5 (5.6)	0.266